Detalles de la búsqueda
1.
Intracranial effect of osimertinib in relapsed EGFR-mutated T790M-positive and -negative non-small cell lung cancer patients: results from a phase II study.
Acta Oncol
; 60(12): 1565-1571, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34486915
2.
Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer.
J Immunother Cancer
; 11(10)2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37852738
3.
Tetracyclines increase the survival of NSCLC patients treated with EGFR TKIs: a retrospective nationwide registry study.
ESMO Open
; 5(5): e000864, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33087401
4.
Elevated CRP levels indicate poor progression-free and overall survival on cancer patients treated with PD-1 inhibitors.
ESMO Open
; 4(4): e000531, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31555483
Resultados
1 -
4
de 4
1
Próxima >
>>